AtriCure (NASDAQ:ATRC) Price Target Raised to $45.00
AtriCure (NASDAQ:ATRC – Free Report) had its price objective increased by Oppenheimer from $36.00 to $45.00 in a report issued on Thursday morning,Benzinga reports. They currently have an outperform rating on the medical device company’s stock. ATRC has been the topic of several other reports. Canaccord Genuity Group raised their target price on AtriCure from […]
AtriCure (NASDAQ:ATRC – Free Report) had its price objective increased by Oppenheimer from $36.00 to $45.00 in a report issued on Thursday morning,Benzinga reports. They currently have an outperform rating on the medical device company’s stock. ATRC has been the topic of several other reports. Canaccord Genuity Group raised their target price on AtriCure from […]
